Effects of retinoic acid on keratinocyte proliferation and differentiation in a psoriatic skin model

Tissue Engineering - Part A

Volumn 17, Issue 13-14, 2011, Pages 1859-1868

  Jean, Jessica ^a,b   Soucy, Jacques ^a   Pouliot, Roxane ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DERMATOLOGY;

ANTI-PROLIFERATIVE; CELL DIFFERENTIATION; DIFFERENTIATION MARKERS; EARLY DIFFERENTIATION; GROWTH FACTOR; IMMUNOLABELING; IN-VIVO; KERATINOCYTES; RETINOIC ACIDS; RETINOIDS; SELF-ASSEMBLY METHOD; SKIN DISEASE; SKIN MODEL;

SKIN;

BIOLOGICAL MARKER; RETINOIC ACID; TP63 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; BIOLOGICAL MODEL; CELL DIFFERENTIATION; CELL PROLIFERATION; DRUG EFFECT; EPIDERMIS; FEMALE; HUMAN; KERATINOCYTE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PSORIASIS; SKIN;

ADULT; AGED; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL PROLIFERATION; EPIDERMIS; FEMALE; HUMANS; KERATINOCYTES; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PSORIASIS; SKIN; TRANSCRIPTION FACTORS; TRETINOIN; TUMOR SUPPRESSOR PROTEINS;

EID: 79959562516     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0463     Document Type: Article

References (62)

1. Sugihara, H., Toda, S., Miyabara, S., et al. Reconstruction of the skin in three-dimensional collagen gel matrix culture. In Vitro Cell Dev Biol 27 A, 142, 1991.
2. Bragulla, H. H., and Homberger, D. G. Structure and functions of keratin proteins in simple, stratified, keratinized and cornified epithelia. J Anat 214, 516, 2009.
3. Nagarajan, P., Parikh, N., Garrett-Sinha, L. A., et al. Ets1 induces dysplastic changes when expressed in terminally-differentiating squamous epidermal cells. PLoS ONE 4, e4179, 2009.
4. Harding, C. R. The stratum corneum: structure and function in health and disease. Dermatol Ther 17 Suppl 1, 6, 2004.
5. Ivanova, P., Atanasova, G., Poumay, Y., et al. Knockdown of PKD1 in normal human epidermal keratinocytes increases mRNA expression of keratin 10 and involucrin: early markers of keratinocyte differentiation. Arch Dermatol Res 300, 139, 2008.
6. Iizuka, H., Takahashi, H., Honma, M., et al. Unique keratinization process in psoriasis: late differentiation markers are abolished because of the premature cell death. J Dermatol 31, 271, 2004.
7. Poumay, Y., Herphelin, F., Smits, P., et al. High-cell-density phorbol ester and retinoic acid upregulate involucrin and downregulate suprabasal keratin 10 in autocrine cultures of human epidermal keratinocytes. Mol Cell Biol Res Commun 2, 138, 1999.
8. Choi, Y., and Fuchs, E. TGF-beta and retinoic acid: regulators of growth and modifiers of differentiation in human epidermal cells. Cell Regul 1, 791, 1990.
9. Rashmi, R., Rao, K. S., and Basavaraj, K. H. A comprehensive review of biomarkers in psoriasis. Clin Exp Dermatol 34, 658, 2009.
10. Karlsson, T., Rollman, O., Vahlquist, A., et al. Immunofluorescence localization of nuclear retinoid receptors in psoriasis versus normal human skin. Acta Derm Venereol 84, 363, 2004.
11. Lowes, M. A., Bowcock, A. M., and Krueger, J. G. Pathogenesis and therapy of psoriasis. Nature 445, 866, 2007.
12. Fitzpatrick, T. B., and Wolff, K. Fitzpatrick's Dermatology in General Medicine. Seventh edition. New York: Medical, M.-H., 2008.
13. Bagel, J. Topical therapies for the treatment of plaque psoriasis. Cutis 84, 3, 2009.
14. Boehncke, W. H., Boehncke, S., and Schon, M. P. Managing comorbid disease in patients with psoriasis. BMJ 340, b5666, 2010.
15. Ovalle, W. K., and Nahirney, P. C. Netter's Essential Histology. First Edition. Philadelphia: Saunders/Elsevier, 2008.
16. Sullivan-Whalen, M., and Gilleaudeau, P. Psoriasis: hope for the future. Nurs Clin North Am 42, 467, 2007.
17. Fadzil, M. H., Ihtatho, D., Affandi, A. M., et al. Area assessment of psoriasis lesions for PASI scoring. J Med Eng Technol 33, 426, 2009.
18. Smit, J. V., Franssen, M. E., de Jong, E. M., et al. A phase II multicenter clinical trial of systemic bexarotene in psoriasis. J Am Acad Dermatol 51, 249, 2004.
19. van de Kerkhof, P. C. Update on retinoid therapy of psoriasis in: an update on the use of retinoids in dermatology. Dermatol Ther 19, 252, 2006.
20. Harper, R. A. Specificity in the synergism between retinoic acid and EGF on the growth of adult human skin fibroblasts. Exp Cell Res 178, 254, 1988.
21. Lee, D. D., Stojadinovic, O., Krzyzanowska, A., et al. Retinoid-responsive transcriptional changes in epidermal keratinocytes. J Cell Physiol 220, 427, 2009.
22. van Steensel, M. A. Emerging drugs for ichthyosis. Expert Opin Emerg Drugs 12, 647, 2007.
23. Niles, R. M. The use of retinoids in the prevention and treatment of skin cancer. Expert Opin Pharmacother 3, 299, 2002.
24. Verfaille, C. J., Borgers, M., and van Steensel, M. A. Retinoic acid metabolism blocking agents (RAMBAs): a new paradigm in the treatment of hyperkeratotic disorders. J Dtsch Dermatol Ges 6, 355, 2008.
25. Zhang, C., and Duvic, M. Treatment of cutaneous T-cell lymphoma with retinoids. Dermatol Ther 19, 264, 2006.
26. Bovenschen, H. J., Otero, M. E., Langewouters, A. M., et al. Oral retinoic acid metabolism blocking agent Rambazole for plaque psoriasis: an immunohistochemical study. Br J Dermatol 156, 263, 2007.
27. Aneskievich, B. J., and Fuchs, E. Terminal differentiation in keratinocytes involves positive as well as negative regulation by retinoic acid receptors and retinoid X receptors at retinoid response elements. Mol Cell Biol 12, 4862, 1992.
28. Fuchs, E., and Green, H. Regulation of terminal differentiation of cultured human keratinocytes by vitamin A. Cell 25, 617, 1981.
29. Varani, J., Perone, P., Griffiths, C. E., et al. All-trans retinoic acid (RA) stimulates events in organ-cultured human skin that underlie repair. Adult skin from sun-protected and sunexposed sites responds in an identical manner to RA while neonatal foreskin responds differently. J Clin Invest 94, 1747, 1994.
30. Parisotto, M., Brodeur, H., Bhat, P. V., et al. [Retinoid metabolism and cancer]. Med Sci (Paris) 22, 1101, 2006.
31. Njar, V. C., Gediya, L., Purushottamachar, P., et al.. Retinoic acid metabolism blocking agents (RAMBAs) for treatmentofcancer and dermatological diseases. Bioorg Med Chem 14, 4323, 2006.
32. Rollman, O., Wood, E. J., Olsson, M. J., et al. Biosynthesis of 3, 4-didehydroretinol from retinol by human skin keratinocytes in culture. Biochem J 293(Pt 3), 675, 1993.
33. Xiao, J. H., Feng, X., Di, W., et al. Identification of heparinbinding EGF-like growth factor as a target in intercellular regulation of epidermal basal cell growth by suprabasal retinoic acid receptors. EMBO J 18, 1539, 1999.
34. Chapellier, B., Mark, M., Messaddeq, N., et al. Physiological and retinoid-induced proliferations of epidermis basal keratinocytes are differently controlled. EMBO J 21, 3402, 2002.
35. Germain, L., Rouabhia, M., Guignard, R., et al. Improvement of human keratinocyte isolation and culture using thermolysin. Burns 19, 99, 1993.
36. Germain, L., and Auger, F. A. Tissue-engineered biomaterials: biological and mechanical characteristics. In: Wise, D. L., Trantolo, D. J., Altobelli, D. E., Yaszemski, M. J., Gresser, J. D., and Schwartz, E. R., eds. Encyclopedic Handbook of Biomaterials and Bioengineering, part B, Vol. 1. New York: Marcel Dekker, 1995, pp. 699-734.
37. Auger, F. A., Lopez Valle, C. A., Guignard, R., et al. Skin equivalent produced with human collagen. In Vitro Cell Dev Biol Anim 31, 432, 1995.
38. Jean, J., Lapointe, M., Soucy, J., et al. Development of an in vitro psoriatic skin model by tissue engineering. J Dermatol Sci 53, 19, 2009.
39. Bernard, G., Auger, M., Soucy, J., et al. Physical characterization of the stratum corneum of an in vitro psoriatic skin model by ATR-FTIR and Raman spectroscopies. Biochim Biophys Acta 1770, 1317, 2007.
40. Michel, M., L'Heureux, N., Pouliot, R., et al. Characterization of a new tissue-engineered human skin equivalent with hair. In Vitro Cell Dev Biol Anim 35, 318, 1999.
41. McGowan, K. M., and Coulombe, P. A. Onset of keratin 17 expression coincides with the definition of major epithelial lineages during skin development. J Cell Biol 143, 469, 1998.
42. Heise, R., Mey, J., Neis, M. M., et al. Skin retinoid concentrations are modulated by CYP26AI expression restricted to basal keratinocytes in normal human skin and differentiated 3D skin models. J Invest Dermatol 126, 2473, 2006.
43. Gottlieb, S., Hayes, E., Gilleaudeau, P., et al. Cellular actions of etretinate in psoriasis: enhanced epidermal differentiation and reduced cell-mediated inflammation are unexpected outcomes. J Cutan Pathol 23, 404, 1996.
44. Dierlich, E., Orfanos, C. E., Pullmann, H., et al. [Beneficial effect of oral retinoid in psoriatic hyperproliferation. Autoradiographic studies on involved and non involved skin (author's transl)]. Arch Dermatol Res 264, 169, 1979.
45. Feng, S., Lin, L., Wu, Q., et al. Study on the expression of RXRalpha in patients with psoriasis vulgaris. Eur J Dermatol 16, 33, 2006.
46. Giltaire, S., Herphelin, F., Frankart, A., et al. The CYP26 inhibitor R115866 potentiates the effects of all-trans retinoic acid on cultured human epidermal keratinocytes. Br J Dermatol 160, 505, 2009.
47. Antiga, E., Volpi, W., Chiarini, C., et al. The role of etanercept on the expression of markers of T helper 17 cells and their precursors in skin lesions of patients with psoriasis vulgaris. Int J Immunopathol Pharmacol 23, 767, 2010.
48. Tonel, G., Conrad, C., Laggner, U., et al. Cutting edge: a critical functional role for IL-23 in psoriasis. J Immunol 185, 5688, 2010.
49. Elias, K. M., Laurence, A., Davidson, T. S., et al. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 111, 1013, 2008.
50. Ikeda, U., Wakita, D., Ohkuri, T., et al. 1alpha, 25-Dihydroxyvitamin D3 and all-trans retinoic acid synergistically inhibit the differentiation and expansion of Th17 cells. Immunol Lett 134, 7, 2010.
51. Mucida, D., Park, Y., Kim, G., et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317, 256, 2007.
52. Orfanos, C. E., Zouboulis, C. C., Almond-Roesler, B., et al. Current use and future potential role of retinoids in dermatology. Drugs 53, 358, 1997.
53. Pang, M. L., Murase, J. E., and Koo, J. An updated review of acitretin-a systemic retinoid for the treatment of psoriasis. Expert Opin Drug Metab Toxicol 4, 953, 2008.
54. Trapasso, E., Cosco, D., Celia, C., et al. Retinoids: new use by innovative drug-delivery systems. Expert Opin Drug Deliv 6, 465, 2009.
55. Dubertret, L. Retinoids, methotrexate and cyclosporine. Curr Probl Dermatol 38, 79, 2009.
56. Liu, Y., Krueger, J. G., and Bowcock, A. M. Psoriasis: genetic associations and immune system changes. Genes Immun 8, 1, 2007.
57. Schon, M. P., and Boehncke, W. H. Psoriasis. N Engl J Med 352, 1899, 2005.
58. Asselineau, D., Dale, B. A., and Bernard, B. A. Filaggrin production by cultured human epidermal keratinocytes and its regulation by retinoic acid. Differentiation 45, 221, 1990.
59. Weinstein, G. D., Nigra, T. P., Pochi, P. E., et al. Topical tretinoin for treatment of photodamaged skin. A multicenter study. Arch Dermatol 127, 659, 1991.
60. Gilchrest, B. A. Turning back the clock: retinoic acid modifies intrinsic aging changes. J Clin Invest 94, 1711, 1994.
61. Bhawan, J., Gonzalez-Serva, A., Nehal, K., et al. Effects of tretinoin on photodamaged skin. A histologic study. Arch Dermatol 127, 666, 1991.
62. Bernard, F. X., Pedretti, N., Rosdy, M., et al. Comparison of gene expression profiles in human keratinocyte monolayer cultures, reconstituted epidermis and normal human skin; transcriptional effects of retinoid treatments in reconstituted human epidermis. Exp Dermatol 11, 59, 2002.